Sara Galimberti

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi

Massimo Federico, Stefano Luminari, Alessandra Dondi et al. · Journal of Clinical Oncology · 2013 · 264 citations · Full text

Medicine, Oncology, Pharmacology +12

Suspension of Bone Marrow–Derived Undifferentiated Mesenchymal Stromal Cells for Repair of Superficial Digital Flexor Tendon in Race Horses

Simone Pacini, S. Spinabella, Luisa Trombi et al. · Tissue Engineering · 2007 · 231 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms

Chiara Baldini, Francesca Romana Moriconi, Sara Galimberti et al. · European Heart Journal · 2021 · 160 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

Francesco Merli, Stefano Luminari, Fiorella Ilariucci et al. · British Journal of Haematology · 2011 · 133 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14